Page last updated: 2024-08-16

riluzole and morphine

riluzole has been researched along with morphine in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (21.43)18.2507
2000's7 (50.00)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Schmidt, WJ; Tzschentke, TM1
Astorga, JG; Contreras, E; Sepúlveda, J1
Abarca, C; Contreras, E; Oliva, P; Sepúlveda, MJ; Silva, E1
Jokelainen, M1
Ji, RR; Lim, G; Mao, J; Sung, B1
Araki, H; Gomita, Y; Hamamura, T; Jin, C; Kawasaki, H; Kawasaki, Y; Nagata, M; Shibata, K; Suemaru, K1
Amin, M; Rawls, SM; Robinson, W; Tallarida, R1
Böhmer, AE; Crestana, RH; Dalmaz, C; Elisabetsky, E; Hansel, G; Knorr, L; Lara, DR; Schallenberger, C; Schmidt, AP; Silveira, PP; Souza, DO; Tort, AB1
Charkhpour, M; Habibi-Asl, B; Hassanzadeh, K1
Arasteh, M; Farajnia, S; Habibi-asl, B; Hassanzadeh, K; Izadpanah, E; Mohammadi, S; Nemati, M; Roshangar, L1

Reviews

2 review(s) available for riluzole and morphine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Pharmacotherapy of amyotrophic lateral sclerosis].
    Duodecim; laaketieteellinen aikakauskirja, 1997, Volume: 113, Issue:6

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Anti-Anxiety Agents; Disease Progression; Female; Humans; Male; Middle Aged; Morphine; Neuroprotective Agents; Prognosis; Riluzole; Severity of Illness Index; Terminal Care

1997

Other Studies

12 other study(ies) available for riluzole and morphine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole.
    Neuroscience letters, 1998, Feb-13, Volume: 242, Issue:2

    Topics: Amphetamine; Animals; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychological; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Reward; Riluzole; Substance-Related Disorders

1998
Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice.
    European journal of pharmacology, 1999, Aug-20, Volume: 379, Issue:1

    Topics: Analgesics, Opioid; Animals; Drug Interactions; Female; Mice; Morphine; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Riluzole; Substance Withdrawal Syndrome; Time Factors

1999
Neurochemical changes after morphine, dizocilpine or riluzole in the ventral posterolateral thalamic nuclei of rats with hyperalgesia.
    European journal of pharmacology, 2000, Sep-01, Volume: 403, Issue:1-2

    Topics: Analysis of Variance; Animals; Arginine; Aspartic Acid; Carrageenan; Citrulline; Dialysis Solutions; Dizocilpine Maleate; Dose-Response Relationship, Drug; Glutamic Acid; Hindlimb; Hyperalgesia; Male; Microdialysis; Morphine; Neuroprotective Agents; Rats; Rats, Wistar; Riluzole; Thalamic Nuclei

2000
Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Sep-15, Volume: 22, Issue:18

    Topics: Amino Acid Transport System X-AG; Analgesics; Animals; Behavior, Animal; Down-Regulation; Drug Administration Schedule; Drug Tolerance; Excitatory Amino Acid Antagonists; Hyperesthesia; Injections, Spinal; Male; Morphine; Morphine Dependence; Narcotic Antagonists; Neuroglia; Neurons; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Riluzole; Spinal Cord; Time

2002
The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Brain research, 2006, Jan-19, Volume: 1069, Issue:1

    Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Cell Count; Conditioning, Operant; Drug Interactions; Excitatory Amino Acid Antagonists; Gene Expression; Immunohistochemistry; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Riluzole

2006
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats.
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Analgesics, Opioid; Analysis of Variance; Animals; Anti-Bacterial Agents; Aspartic Acid; beta-Lactams; Body Temperature; Ceftriaxone; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Rats; Rats, Sprague-Dawley; Riluzole; Time Factors

2007
The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:4

    Topics: Animals; Chromatography, High Pressure Liquid; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Guanosine; Hyperalgesia; Male; Morphine; Narcotics; Pain Measurement; Rats; Rats, Wistar; Reaction Time; Receptors, N-Methyl-D-Aspartate; Riluzole

2009
Central administration of minocycline and riluzole prevents morphine-induced tolerance in rats.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:3

    Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Tolerance; Glutamic Acid; Male; Minocycline; Morphine; Morphine Dependence; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Riluzole

2009
Riluzole prevents morphine-induced apoptosis in rat cerebral cortex.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:3

    Topics: Analgesics, Opioid; Animals; Apoptosis; Caspase 3; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Glutamic Acid; HSP70 Heat-Shock Proteins; In Situ Nick-End Labeling; Injections, Intraventricular; Male; Morphine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Riluzole

2011
chemdatabank.com